SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001860782-24-000048
Filing Date
2024-04-01
Accepted
2024-04-01 07:47:34
Documents
16
Period of Report
2024-03-29
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20240329.htm   iXBRL 8-K 36070
2 EX-10.1 a-conformedfor8xkexxnickle.htm EX-10.1 55668
3 EX-99.1 exhibit991unauditedproform.htm EX-99.1 134344
4 EX-99.2 pressrelease-firefoxclosing.htm EX-99.2 13387
  Complete submission text file 0001860782-24-000048.txt   397602

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20240329.xsd EX-101.SCH 2010
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20240329_lab.xml EX-101.LAB 22530
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20240329_pre.xml EX-101.PRE 13144
19 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20240329_htm.xml XML 2808
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 24805580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)